#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	6150	16S	1529	1529	99.93	16S.l6.c4.ctg.1	3136	471.8	0	.	n	.	0	C1450T	SNP	1450	1450	C	2318	2318	T	736	T,G,A	700,5,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	6150	16S	1529	1529	99.93	16S.l6.c4.ctg.1	3136	471.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	2052	2052	C	665	C,G	637,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	9464	23S	2890	2890	99.93	23S.l6.c4.ctg.1	4356	532.5	0	.	n	.	0	G1337A	SNP	1337	1337	G	2097	2097	A	676	A,T	651,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	9464	23S	2890	2890	99.93	23S.l6.c4.ctg.1	4356	532.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2731	2731	C	673	C,T,A,G	636,2,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	9464	23S	2890	2890	99.93	23S.l6.c4.ctg.1	4356	532.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2805	2805	A	669	A	640	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	9464	23S	2890	2890	99.93	23S.l6.c4.ctg.1	4356	532.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	3357	3357	C	515	C,A	503,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	9464	23S	2890	2890	99.93	23S.l6.c4.ctg.1	4356	532.5	0	HET	.	.	.	C709T,A,G	.	709	709	C	1469	1469	C	621	C,T,A,G	459,131,2,1	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	283	708	folP	855	855	100.0	folP.l15.c4.ctg.1	2258	75.0	1	SNP	p	R229S	1	.	.	685	687	AGC	1513	1515	AGC	96;96;94	A;G;C,G	96;96;92,1	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	155	1512	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	4042	91.2	1	SNP	p	S91F	1	.	.	271	273	TTC	975	977	TTC	70;70;70	T;T;C	69;69;70	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	155	1512	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	4042	91.2	1	SNP	p	D95G	1	.	.	283	285	GGC	987	989	GGC	72;72;73	G;G;C,A	70;71;67,1	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	155	1512	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	4042	91.2	1	SNP	p	G95N	0	.	.	283	285	GGC	987	989	GGC	72;72;73	G;G;C,A	70;71;67,1	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	155	1512	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	4042	91.2	0	HET	.	.	.	G2377A,C	.	2377	2377	G	3081	3081	G	77	G,A,C	51,10,1	.	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	155	1512	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	4042	91.2	0	HET	.	.	.	C2389A	.	2389	2389	C	3093	3093	C	72	C,A	60,9	.	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	155	1512	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	4042	91.2	0	HET	.	.	.	G2310T,C	.	2310	2310	G	3014	3014	G	96	G,T,C	41,14,1	.	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	155	1512	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	4042	91.2	0	HET	.	.	.	C2320G	.	2320	2320	C	3024	3024	C	92	C,G	48,20	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	576	mtrR	633	633	100.0	mtrR.l6.c4.ctg.1	2020	70.5	1	SNP	p	G45D	0	.	.	133	135	GGC	829	831	GGC	161;162;162	G;G;C	150;148;155	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	392	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1828	52.5	0	.	n	.	0	A197.	DEL	197	197	A	1005	1005	A	115	A	114	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	1312	parC	2304	2304	99.87	parC.l15.c4.ctg.1	3587	88.8	0	.	p	.	0	I384V	NONSYN	1150	1152	ATC	1849	1851	GTC	139;137;137	G;T,G;C	128;122,2;127	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	1312	parC	2304	2304	99.87	parC.l15.c4.ctg.1	3587	88.8	1	SNP	p	D86N	0	.	.	256	258	GAC	955	957	GAC	77;77;78	G;A,G;C	62;44,1;62	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	1312	parC	2304	2304	99.87	parC.l15.c4.ctg.1	3587	88.8	1	SNP	p	R87I	0	.	.	259	261	CGT	958	960	CGT	78;79;81	C;G;T	68;53;59	parC.WHO_V_00204c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	1312	parC	2304	2304	99.87	parC.l15.c4.ctg.1	3587	88.8	1	SNP	p	S87R	1	.	.	259	261	CGT	958	960	CGT	78;79;81	C;G;T	68;53;59	parC.WHO_V_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	1312	parC	2304	2304	99.87	parC.l15.c4.ctg.1	3587	88.8	1	SNP	p	R87W	0	.	.	259	261	CGT	958	960	CGT	78;79;81	C;G;T	68;53;59	parC.WHO_V_00204c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	1312	parC	2304	2304	99.87	parC.l15.c4.ctg.1	3587	88.8	1	SNP	p	S88P	0	.	.	262	264	TCC	961	963	TCC	81;81;81	T,G;C,T;C	68,1;65,2;73	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	1454	parE	1986	1986	99.95	parE.l15.c4.ctg.1	3465	102.7	0	.	p	.	0	R340C	NONSYN	1018	1020	CGC	1804	1806	TGC	152;152;150	T,G;G;C,G	127,1;132;125,1	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	1454	parE	1986	1986	99.95	parE.l15.c4.ctg.1	3465	102.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	2014	2016	GGC	113;114;114	G;G,C;C	98;96,1;92	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.12.001	penA.12.001	1	1	27	1174	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2666	105.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1640	1642	GCA	161;163;163	G,A,C;C,A;A,C	147,2,1;150,1;146,1	penA.12.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	1174	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2666	105.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1643	1645	ATC	165;165;165	A,T;T;C,A	149,1;159;158,1	penA.12.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	1174	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2666	105.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1655	1657	GTG	164;164;164	G;T,G;G	156;149,2;155	penA.12.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	1174	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2666	105.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1655	1657	GTG	164;164;164	G;T,G;G	156;149,2;155	penA.12.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	1174	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2666	105.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2159	2161	ACC	69;69;68	A,C;C;C	54,1;63;64	penA.12.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	1174	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2666	105.2	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2213	2215	GCG	62;62;62	G;C;G	51;46;50	penA.12.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	1174	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2666	105.2	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2213	2215	GCG	62;62;62	G;C;G	51;46;50	penA.12.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	1174	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2666	105.2	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2336	2338	GGC	84;84;84	G,T;G,T,A;C,T,G	81,1;77,2,1;73,6,2	penA.12.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	1174	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2666	105.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2345	2347	GGC	83;83;84	G;G;C,G	79;60;45,1	penA.12.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	1174	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2666	105.2	1	SNP	p	P552S	1	.	.	1654	1656	TCG	2363	2365	TCG	89;89;89	T,G;C,G;G	46,4;63,1;74	penA.12.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1716	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3855	108.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	2062	2064	CCG	144;144;144	C,G,T;C,T;G,C,T	100,4,2;130,1;98,2,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	692	porA	1146	1146	99.56	porA.l15.c4.ctg.1	2572	65.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	948	948	C	47	C	41	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	922	porB1b	1047	1047	99.33	porB1b.l15.c4.ctg.1	2386	94.0	0	.	p	.	0	N38E	NONSYN	112	114	AAT	828	830	GAA	103;103;105	G;A,C;A	103;102,1;105	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	922	porB1b	1047	1047	99.33	porB1b.l15.c4.ctg.1	2386	94.0	0	.	p	.	0	N134D	NONSYN	400	402	AAT	1116	1118	GAT	123;127;127	G,T,A;A;T	110,1,1;118;113	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	922	porB1b	1047	1047	99.33	porB1b.l15.c4.ctg.1	2386	94.0	0	.	p	.	0	P175S	NONSYN	523	525	CCA	1239	1241	TCA	109;109;109	T,G,C;C;A,C	101,1,1;102;102,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	922	porB1b	1047	1047	99.33	porB1b.l15.c4.ctg.1	2386	94.0	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1368	1370	GTC	107;111;111	G,T;T;C,A	89,1;102;95,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	922	porB1b	1047	1047	99.33	porB1b.l15.c4.ctg.1	2386	94.0	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1698	1700	GCA	158;156;156	G;C,A;A	155;152,1;153	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	922	porB1b	1047	1047	99.33	porB1b.l15.c4.ctg.1	2386	94.0	1	SNP	p	G120K	1	.	.	358	360	AAG	1074	1076	AAG	138;138;139	A;A,C;G,C,A	134;134,1;133,2,1	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	922	porB1b	1047	1047	99.33	porB1b.l15.c4.ctg.1	2386	94.0	1	SNP	p	A121D	1	.	.	361	363	GAC	1077	1079	GAC	139;140;138	G;A,G;C,A	134;136,1;132,1	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	922	porB1b	1047	1047	99.33	porB1b.l15.c4.ctg.1	2386	94.0	1	SNP	p	D121N	0	.	.	361	363	GAC	1077	1079	GAC	139;140;138	G;A,G;C,A	134;136,1;132,1	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	3696	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5385	168.5	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2248	2250	AAT	209;206;206	A,C;A,T;T,G	203,1;198,1;199,1	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	546	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1785	75.7	1	SNP	p	V57M	1	.	.	169	171	ATG	879	881	ATG	145;146;148	A;T;G	136;143;145	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
